InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Bernard Thierry, 董事. Director active across 2 companies, notably T2 Biosystems, Inc.. Cumulatively, 8 disclosures have been logged. Activity tracked since 1 November 2024. The latest transaction was filed on 23 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Bernard Thierry is Administrateur at T2 Biosystems, Inc. and NEOGEN CORP. He has 8 filings in total, and in the recent sample of 8 filings, the transactions run from 2021-08-09 to 2025-10-27, with Levée d'options as the modal transaction nature.